An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bristol Myers Squibb (BMY) will release its Q4 2023 results on February 2, 2024, with a conference call for investors and analysts at 8:00 a.m. ET. The live webcast can be accessed at http://investor.bms.com, and materials will be available prior to the call. A replay will also be available on the same website.
Positive
None.
Negative
None.
PRINCETON, N.J.--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) will announce results for the fourth quarter of 2023 on Friday, February 2, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the U.S. toll free 1-833-816-1116 or international +1 412-317-0705. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on February 2, 2024, through 11:30 a.m. ET on February 16, 2024, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 1212122.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
When will Bristol Myers Squibb (BMY) release its Q4 2023 results?
Bristol Myers Squibb (BMY) will release its Q4 2023 results on February 2, 2024.
What time will the conference call for investors and analysts begin?
The conference call for investors and analysts will begin at 8:00 a.m. ET on February 2, 2024.
Where can investors and the public access the live webcast of the call?
Investors and the public can access the live webcast of the call at http://investor.bms.com.
How can investors and the public register for the live conference call?
Investors and the public can register for the live conference call at http://investor.bms.com.
Where will materials related to the call be available?
Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
When will the replay of the webcast be available?
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.
How long will the replay of the conference call be available?
A replay of the conference call will be available from 11:30 a.m. ET on February 2, 2024, through 11:30 a.m. ET on February 16, 2024, at http://investor.bms.com.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
